Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply

Additional Metadata
Persistent URL	doi.org/10.1016/S1474-4422(14)70097-3, hdl.handle.net/1765/53551
Journal	The Lancet Neurology
Organisation	Department of Cardio-Thoracic Surgery
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Greenberg, S., Salman, R. A.-S., Biessels, G. J., van Buchem, M., Cordonnier, C., Lee, J.-M., … Werring, D. (2014). Developing biomarkers for cerebral amyloid angiopathy trials: Do potential disease phenotypes hold promise? - Authors' reply. The Lancet Neurology, 13(6). doi:10.1016/S1474-4422(14)70097-3

Publication